• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Sponsored Post
    • Make a Contribution
  • Technology Events 2022-2023
  • Technology Domains
  • Technology Markets
  • Venture Capital
  • Contact
    • About

The Future of AI in DNA Sequencing and Analysis

January 12, 2019 By Technologies.org Leave a Comment

Because of AI, DNA is not destiny; people can now have the knowledge and power to make DNA work for them in industries such as medical cannabis and precision medicine

Executives from Frelii Inc. (OTCQB: FRLI) met with potential partners and prospects from industries including medical cannabis, precision medicine, consumer wellness, insurance and hospital systems during the CES conference in Las Vegas, Nevada. The Frelii team discussed recent advancements in artificial intelligence (AI) systems that are fueling an AI-driven revolution in the field of genomics and DNA sequencing.

“The rapid evolution of AI-based DNA sequencing is delivering new insight into the genome coupled with connections and patterns of gene expression at a scale we have never seen before,” said Ian Jenkins, CEO of Frelii. “Our own Frelii AI system stands at the forefront to empower personalized and precision medicine in new and exciting ways. Frelii looks at every data point on the genome and analyzes how each point is interconnected with every other data point. This is a fundamentally different approach to DNA sequencing and analysis. We produce 60 Million data points, vs the typical 400-700 thousand, as with typical consumer level DNA kits. What we end up with are hard facts that say what the human body will do as well as information regarding what it could do when drugs, medications, supplements and lifestyle changes are introduced.”

Companies are turning to Frelii expertise because with its AI, DNA sequencing and analysis can be completed in a matter of hours, as opposed to weeks or months and at a level that expands the frontiers of knowledge by analyzing massive amounts of data. Most consumer DNA kits on the market look at 400,000 to 700,000 data points along the genome, generating approximately 384 outcomes, such as ancestry, diet suggestions or identification of potential health risks. Frelii’s recently improved technology has dramatically increased the data points subject to analysis to more than 60 million data points, which can generate more than 60 million outcomes. To process each data point against the other data points takes billions of gigabytes of data processing for one person’s physiology. Frelii’s high-efficiency Genetic Sequencing and analysis using Frelii’s proprietary technology has increased to greater than 99 percent and 99.999 percent accuracy on whole genome and exome sequencing, respectively.

This computing power enables the company to analyze more complete data. The system looks at physiology and the holistic internal connections with in the human body providing insights for drug developers, medical professionals and consumers.

“AI combined with DNA sequencing is a match made in heaven because it can bring to light previously unexplored connections that can impact entire industries such as the rapidly expanding medical marijuana market to health care at large,” Jenkins said. “AI provides insight into the function of genetic expression and helps removes the guess work.”

For example, one of the ways AI and DNA sequencing can be used optimally is with medical cannabis. Compared to pharmacological information, there is currently very little data related medical cannabis. In recent years, there has been a rapid advancement in worldwide interest in medical uses of cannabis. According to Viridian Capital Advisors, Cannabis-related companies raised nearly $13 billion in 2018 alone. Frelii is investing in its AI to empower medical professionals when seeking to provide, where it is legal, precision dosing of THC, CBD, CBN and terpenes from appropriate strains of cannabis via the right delivery format.

About Frelii Inc.

Frelii Inc. is a medical technology company that uses gene sequencing and artificial intelligence to determine risk and lifestyle modifications. Its technology analyzes the most comprehensive markers (60,000,000+) on the market to date. Frelii’s technology generates accurate and profoundly valuable insight into DNA. Its high-efficiency Genetic Sequencing and analysis using Frelii’s proprietary technology has increased to greater than 99% and 99.999% accuracy on whole genome and exome sequencing, respectively. It opens opportunities never before realized in health care, precision medicine, insurance, corporate wellness as well as personal health and risk identification. For more information, please visit www.frelii.com.

Related

Filed Under: Tech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • Infinitum Electric Raises $80M in Series D Funding Led by Riverstone Holdings to Scale Production of Sustainable Motors
  • Introducing IonQ Forte, Improving Quantum Performance with a Software-Configurable Dynamic Laser System
  • Cloudflare Unveils New SQL Database Offering
  • Cloudflare announces Workers for Platforms
  • Intel is rolling out new processors designed for data centers
  • EU moves to wean itself off Russian fossil fuels
  • A New Hydrogen-Powered Behemoth
  • BAE Systems to Bring Next-Generation Electric Drive System to Heavy-Duty Industrial Vehicle Market
  • MEMS Speakers Are Replacing Balanced Armature Speakers
  • Trends in data and analytics

Media Partners

  • VPNW
  • S3H
  • OPINT
  • Press Media Release
  • OSINT
  • Digital Market
  • Briefly

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Opinion
  • Venture Capital

Copyright © 2015 Technologies.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT